AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $86.27
- 52-wk high
- $96.29
- High
- $87.04
- 52-wk low
- $72.30
- Low
- $85.73
- Prev close
- $86.18
- Mkt cap
- $49.67B
- P/E
- 51.3x
- Volume
- 2.74M
- Fwd P/E
- 25.6x
- Beta
- 0.85
- P/S
- 7.6x
- P/B
- 4.7x
- Profit margin
- +15.4%
- Op margin
- +29.8%
- ROE
- +9.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 6.8% above what analysts expected.
Earnings per share
$0.73 expected
Revenue
No comparable estimate
Q3 2026 guidance
$1.63B to $1.71B
No comparable estimate
Reports Oct 29, 2026, in 49 days
EPS expected
$0.72 to $0.77
Revenue expected
24 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.55B | $1.57B | $1.65B | $1.74B |
| Cost of what it sold | $345.2M | $340.6M | $359.3M | $390.6M |
| Gross profit | $1.21B | $1.23B | $1.29B | $1.35B |
| What it spent | ||||
| Research and development | $280.7M | $267.7M | $263.3M | $278.9M |
| Sales and admin | $514.6M | $602.9M | $522.2M | $561.2M |
| Other operating costs | -$10.8M | -$11.9M | -$10.9M | -$9.2M |
| Total operating expenses | $784.5M | $858.7M | $774.6M | $830.9M |
| What was left | ||||
| Operating profit | $425.1M | $370.3M | $514.7M | $519.5M |
| Profit before tax | $348.4M | $90.4M | $459.0M | $519.8M |
| Tax | $56.1M | $26.2M | $78.3M | $278.4M |
| Net profit | $291.1M | $91.2M | $380.7M | $241.9M |
| EBITDA | $387.6M | $133.1M | $499.9M | $519.5M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Edwards Lifesciences Corporation $EW Stock Holdings Lifted by California State Teachers Retirement System
BullishSep 925,021 Shares in Zimmer Biomet Holdings, Inc. $ZBH Acquired by Jupiter Topco LLC
NeutralSep 4Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day
Leans bearishSep 3Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit 2026
NeutralSep 3UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH
NeutralSep 2Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
Leans bullishSep 1Edwards Lifesciences (EW) SVP, Corporate Controller Andrew Dahl Sells 544 Shares
Leans bearishSep 1Van ECK Associates Corp Decreases Holdings in Edwards Lifesciences Corporation $EW
NeutralSep 1
Macro
31 macro signals shaping EW right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results